ArticleJournal of radiosurgery and SBRT2022
A practical strategy for incorporating the convolution algorithm in Leksell GammaPlan for routine treatment planning
Article in Journal of radiosurgery and SBRT, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Deep Learning-Based Heterogeneity Correction of the Homogeneous Dose Distribution for Single Brain Tumors in Gamma Knife Radiosurgery.Advances in radiation oncology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: This study aims to establish criteria for convolution dose calculations and an efficient procedure to include the heterogeneity effects in GammaKnife radiosurgery (GKRS) treatment plans. Methods and materials: We analyzed 114 GKRS cases of various disease types, tumor locations, sizes, the number of fractions, and prescription doses. There was a total of 205 tumors. CT scans were performed in addition to routine MRI scans for all treatments. All treatment plans were created using the TMR10 algorithm (TMR10). We repeated the dose calculations for this study with the convolution algorithm (Conv). We calculated the ratios between Conv and TMR10 of the treatment volume (TxtVol), the volume covered by half of the prescription dose (TxtVol2), the minimum, maximum, and mean doses in the tumor (minDose, maxDose, and meanDose), and the volume of tumor covered by the prescription isodose (covVol). We then categorized those quantities for locations of tumors represented by the shortest distance of the skull surface from the tumor center (distC) and the tumor edge (distE). [Table: see text]. Results: All six ratios increased with increasing distC and distE. For example, the median minDose ratio increased from 0.885 to 0.933 as distE increased. There was a statistically significant difference in the minDose ratio between tumors of distE < 2 cm and distE ≥ 2 cm. On the other hand, the median maxDose ratio was about 0.933 [0.928-0.939], being almost independent of distE. This suggested a 6.1% overestimation of the delivered dose with TMR10. Conclusion: The heterogeneity effects must be considered for the volume dose calculations by applying the convolution algorithm when the distance of the skull surface from the closest point of the tumor is less than 2 cm to achieve less than 3% accuracy.
Indexed as
Identifiers
37416335PMC10322173What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.